日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

1031例原发性乳腺癌中BRCA1启动子甲基化状态可预测化疗后的良好预后

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkz100
Stefansson, Olafur A; Hilmarsdottir, Holmfridur; Olafsdottir, Kristrun; Tryggvadottir, Laufey; Sverrisdottir, Asgerdur; Johannsson, Oskar T; Jonasson, Jon G; Eyfjord, Jorunn E; Sigurdsson, Stefan
肿瘤
表观遗传
肿瘤免疫
乳腺癌
BRCA1
DNA甲基化
发表日期：2020
文献求助 收藏

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden

冰岛原位乳腺癌发病率模式及导管原位癌治疗与瑞典的差异

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-020-74134-5
Agustsson, Arnar S; Birgisson, Helgi; Agnarsson, Bjarni A; Jonsson, Thorvaldur; Stefansdottir, Hrefna; Wärnberg, Fredrik; Lambe, Mats; Tryggvadottir, Laufey; Sverrisdottir, Asgerdur
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.

Aurora A 是 BRCA2 突变携带者罹患乳腺癌的预后标志物

期刊:Journal of Pathology Clinical Research
影响因子:3.7
doi:10.1002/cjp2.6
Aradottir Margret, Reynisdottir Sigridur T, Stefansson Olafur A, Jonasson Jon G, Sverrisdottir Asgerdur, Tryggvadottir Laufey, Eyfjord Jorunn E, Bodvarsdottir Sigridur K
肿瘤
乳腺癌
肿瘤免疫
发表日期：2015
文献求助 收藏